Alkaline Plant Based Diet
Alkaline Plant Based Diet
Menu

FDA Doesn’t Approve Pathway Genomics’ Cancer Blood Test

By | September 25th, 2015 | Modified - September 25th, 2015
FDA Doesn't Approve Pathway Genomics' Cancer Blood Test
FDA Doesn’t Approve Pathway Genomics’ Cancer Blood Test

Pathway Genomics has developed the CancerIntercept™ Detect liquid biopsy that reportedly detects cancer in the bloodstream, and its product is marketed directly to consumers.

The blood test is a non-invasive way to to screen for the presence of specific genomic markers found in circulating tumor DNA (ctDNA) for up to ten different types of cancer in high risk populations.

If the company’s product works, it would offer many people a relatively inexpensive way to periodically test for cancer allowing for early detection and response.

The company offers the sale of the product and will bill the person’s insurance. Pathway Genomics acknowledges that the insurance company will likely deny the claim, but the company will fight to have the insurance company cover the cost.

If the claim is denied, the person will be responsible for the cost. Purchase is also available outright.

Though preliminary studies have been done and the technology looks promising, the Food FDA has looked into the product and hadn’t found enough evidence to support the company’s claim.

The FDA sent a letter to Jim Plante, Founder and CEO of Pathway Genomics, this week citing a number issues with the product and its marketing model.

The kit contains a medical device and the FDA indicated it has been:

“…unable to identify any Food and Drug Administration (FDA) records reflecting the approval, clearance, or listing of these devices.”

The FDA goes on to state:

“We have also examined published literature and have not found any published evidence that this test or any similar test has been clinically validated as a screening tool for early detection of cancer in high risk individuals… we believe you are offering a high risk test that has not received adequate clinical validation and may harm the public health.

It appears Pathway Genomics had jumped the gun with its release of its cancer detection product, and may have not have followed procedure in marketing directly to consumers, though the technology does look promising.

Tags: ,

ADVERTISEMENT - Why do I see this?
Alklaine Plant Based Diet
Alklaine Plant Based Diet

About Author:

Aqiyl Aniys is the author of the book Alkaline Herbal Medicine, the Alkaline Plant Based Diet book, and the children's book, Faith and Justice eat an Alkaline Plant Based Diet." He received a certificate in plant-based nutrition from Cornell University, a BA in Organizational Behavior and Communications from NYU, worked as an elementary school teacher, and studied social work. He enjoys boxing, kick boxing, cycling, power walking, and basically anything challenging, and his alkaline plant-based diet supports all that he does. Learn more about transitioning to avegan diet using the Dr. Sebi nutritional guide.

ADVERTISEMENT
ADVERTISEMENT